ARDX - CIK 0001437402
ARDELYX, INC. trades as ARDX and has a market capitalization of $1.39 B, making it the #2387 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $407.32M, up 22.1% from the prior year and net income of -$62.00M. This page tracks ARDELYX, INC. through 1,143 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 10 fiscal years ARDELYX, INC.'s revenue grew from $24.03M to $407.32M, a compound annual growth rate of 32.7%. Net profit margin expanded from -153.2% to -15.2% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Proxy materials | DEFA14A | 2026-05-26 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
The largest companies sharing ARDELYX, INC.'s SEC industry classification (pharmaceutical preparations).
ARDELYX, INC. (ARDX) has a market capitalization of $1.39 B as of 2026-06-10, ranking #2387 among US-listed companies.
ARDELYX, INC. reported revenue of $407.32M for fiscal year 2025, an increase of 22.1% year over year.
In its latest fiscal year ARDELYX, INC. reported a net loss of $62.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.